Ubiquitylation of cyclin C by HACE1 regulates cisplatin‐associated sensitivity in gastric cancer-Reference-Cited by-同舟云学术

Ubiquitylation of cyclin C by HACE1 regulates cisplatin‐associated sensitivity in gastric cancer

Published:2022-03 Issue:3 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Jiang Hong‐yue¹^ORCID,Chen Ying‐ling¹,Xu Xing‐xing²,Li Chuan‐yin²³,Chen Yun¹,Li Dong‐ping¹,Zeng Xiao‐qing¹,Gao Hong¹⁴^ORCID

Affiliation:

1. Department of Gastroenterology and Hepatology Zhongshan Hospital Fudan University Shanghai China

2. State Key Laboratory of Molecular Biology CAS Center for Excellence in Molecular Cell Science Innovation Center for Cell Signaling Network Shanghai Institute of Biochemistry and Cell Biology Chinese Academy of Sciences Shanghai China

3. University of Chinese Academy of Sciences Beijing China

4. Evidence‐based Medicine Center of Fudan University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.770

Reference48 articles.

1. Global cancer statistics, 2012

2. Japanese gastric cancer treatment guidelines 2014 (ver. 4)

3. Management of gastric cancer in Asia: resource-stratified guidelines

4. Cyclin C: The Story of a Non-Cycling Cyclin

5. Dysregulation of CDK8 and Cyclin C in tumorigenesis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structural Basis for the Enzymatic Activity of the HACE1 HECT‐Type E3 Ligase Through N‐Terminal Helix Dimerization;Advanced Science;2023-08-03

2. Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer;Pathology and Oncology Research;2023-02-07

3. The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer;International Journal of Molecular Sciences;2023-02-02

4. HACE1 builds molecular crosstalks between rare diseases and (more) common disorders;Clinical and Translational Medicine;2022-06

5. Cyclin C: A new responser for chemosensitivity in cancer;Clinical and Translational Medicine;2022-04